Logo image of CHRD

CHORD ENERGY CORP (CHRD) Stock Fundamental Analysis

NASDAQ:CHRD - Nasdaq - US6742152076 - Common Stock - Currency: USD

103.63  +1.18 (+1.15%)

After market: 103.63 0 (0%)

Fundamental Rating

5

Taking everything into account, CHRD scores 5 out of 10 in our fundamental rating. CHRD was compared to 209 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of CHRD get a neutral evaluation. Nothing too spectacular is happening here. CHRD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CHRD had positive earnings in the past year.
In the past year CHRD had a positive cash flow from operations.
Of the past 5 years CHRD 4 years were profitable.
Each year in the past 5 years CHRD had a positive operating cash flow.
CHRD Yearly Net Income VS EBIT VS OCF VS FCFCHRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

The Return On Assets of CHRD (6.49%) is better than 61.90% of its industry peers.
CHRD's Return On Equity of 9.71% is in line compared to the rest of the industry. CHRD outperforms 49.52% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.29%, CHRD is in line with its industry, outperforming 57.62% of the companies in the same industry.
CHRD had an Average Return On Invested Capital over the past 3 years of 15.70%. This is significantly below the industry average of 27.48%.
The last Return On Invested Capital (7.29%) for CHRD is well below the 3 year average (15.70%), which needs to be investigated, but indicates that CHRD had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.49%
ROE 9.71%
ROIC 7.29%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
CHRD Yearly ROA, ROE, ROICCHRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

CHRD's Profit Margin of 16.10% is fine compared to the rest of the industry. CHRD outperforms 60.95% of its industry peers.
In the last couple of years the Profit Margin of CHRD has declined.
Looking at the Operating Margin, with a value of 20.62%, CHRD is in line with its industry, outperforming 50.00% of the companies in the same industry.
CHRD's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 51.05%, CHRD is in line with its industry, outperforming 56.67% of the companies in the same industry.
CHRD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.62%
PM (TTM) 16.1%
GM 51.05%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
CHRD Yearly Profit, Operating, Gross MarginsCHRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

4

2. Health

2.1 Basic Checks

CHRD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CHRD has been increased compared to 1 year ago.
Compared to 5 years ago, CHRD has less shares outstanding
Compared to 1 year ago, CHRD has a worse debt to assets ratio.
CHRD Yearly Shares OutstandingCHRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CHRD Yearly Total Debt VS Total AssetsCHRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

CHRD has an Altman-Z score of 1.77. This is a bad value and indicates that CHRD is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.77, CHRD is doing good in the industry, outperforming 60.95% of the companies in the same industry.
CHRD has a debt to FCF ratio of 3.20. This is a good value and a sign of high solvency as CHRD would need 3.20 years to pay back of all of its debts.
The Debt to FCF ratio of CHRD (3.20) is better than 73.81% of its industry peers.
CHRD has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CHRD (0.10) is better than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.2
Altman-Z 1.77
ROIC/WACC0.84
WACC8.69%
CHRD Yearly LT Debt VS Equity VS FCFCHRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.94 indicates that CHRD may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.94, CHRD is doing worse than 62.38% of the companies in the same industry.
CHRD has a Quick Ratio of 0.94. This is a bad value and indicates that CHRD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, CHRD perfoms like the industry average, outperforming 42.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.88
CHRD Yearly Current Assets VS Current LiabilitesCHRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CHRD have decreased strongly by -16.89% in the last year.
CHRD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.52% yearly.
The Revenue has grown by 34.76% in the past year. This is a very strong growth!
The Revenue has been growing by 20.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.89%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-33.52%
Revenue 1Y (TTM)34.76%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%50.79%

3.2 Future

CHRD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.66% yearly.
The Revenue is expected to decrease by -1.60% on average over the next years.
EPS Next Y-21.68%
EPS Next 2Y-6.99%
EPS Next 3Y-1.66%
EPS Next 5YN/A
Revenue Next Year-3.88%
Revenue Next 2Y-1.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHRD Yearly Revenue VS EstimatesCHRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
CHRD Yearly EPS VS EstimatesCHRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.21 indicates a rather cheap valuation of CHRD.
Based on the Price/Earnings ratio, CHRD is valued cheaply inside the industry as 82.38% of the companies are valued more expensively.
CHRD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
The Price/Forward Earnings ratio is 7.93, which indicates a rather cheap valuation of CHRD.
Based on the Price/Forward Earnings ratio, CHRD is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CHRD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.21
Fwd PE 7.93
CHRD Price Earnings VS Forward Price EarningsCHRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHRD is valued cheaply inside the industry as 81.90% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as CHRD.
Industry RankSector Rank
P/FCF 23.48
EV/EBITDA 3.19
CHRD Per share dataCHRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.99%
EPS Next 3Y-1.66%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.93%, CHRD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.12, CHRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, CHRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

CHRD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CHRD Yearly Dividends per shareCHRD Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 5 10 15 20 25

5.3 Sustainability

62.70% of the earnings are spent on dividend by CHRD. This is not a sustainable payout ratio.
DP62.7%
EPS Next 2Y-6.99%
EPS Next 3Y-1.66%
CHRD Yearly Income VS Free CF VS DividendCHRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
CHRD Dividend Payout.CHRD Dividend Payout, showing the Payout Ratio.CHRD Dividend Payout.PayoutRetained Earnings

CHORD ENERGY CORP

NASDAQ:CHRD (3/7/2025, 8:13:43 PM)

After market: 103.63 0 (0%)

103.63

+1.18 (+1.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners90.51%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner Change-3.76%
Market Cap6.18B
Analysts80.87
Price Target169.38 (63.45%)
Short Float %2.79%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend10.46
Dividend Growth(5Y)N/A
DP62.7%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-11 2025-03-11 (1.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.01%
Min EPS beat(2)-11.89%
Max EPS beat(2)21.92%
EPS beat(4)2
Avg EPS beat(4)1.45%
Min EPS beat(4)-11.89%
Max EPS beat(4)21.92%
EPS beat(8)4
Avg EPS beat(8)5.28%
EPS beat(12)5
Avg EPS beat(12)1.63%
EPS beat(16)9
Avg EPS beat(16)10.7%
Revenue beat(2)2
Avg Revenue beat(2)13.41%
Min Revenue beat(2)9.22%
Max Revenue beat(2)17.6%
Revenue beat(4)4
Avg Revenue beat(4)21.72%
Min Revenue beat(4)9.22%
Max Revenue beat(4)36.47%
Revenue beat(8)8
Avg Revenue beat(8)22.75%
Revenue beat(12)12
Avg Revenue beat(12)34.51%
Revenue beat(16)16
Avg Revenue beat(16)36.68%
PT rev (1m)-0.56%
PT rev (3m)-7.52%
EPS NQ rev (1m)2.21%
EPS NQ rev (3m)-3.47%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-7.35%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-1.94%
Valuation
Industry RankSector Rank
PE 6.21
Fwd PE 7.93
P/S 1.18
P/FCF 23.48
P/OCF 2.95
P/B 0.71
P/tB 0.76
EV/EBITDA 3.19
EPS(TTM)16.68
EY16.1%
EPS(NY)13.06
Fwd EY12.61%
FCF(TTM)4.41
FCFY4.26%
OCF(TTM)35.17
OCFY33.94%
SpS88.06
BVpS145.94
TBVpS137.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.49%
ROE 9.71%
ROCE 9.54%
ROIC 7.29%
ROICexc 7.31%
ROICexgc 7.67%
OM 20.62%
PM (TTM) 16.1%
GM 51.05%
FCFM 5.01%
ROA(3y)16.4%
ROA(5y)-22.23%
ROE(3y)23.16%
ROE(5y)-60.5%
ROIC(3y)15.7%
ROIC(5y)15.04%
ROICexc(3y)17%
ROICexc(5y)16.36%
ROICexgc(3y)17.12%
ROICexgc(5y)16.47%
ROCE(3y)20.55%
ROCE(5y)19.7%
ROICexcg growth 3Y-34.65%
ROICexcg growth 5Y32.44%
ROICexc growth 3Y-35.69%
ROICexc growth 5Y31.18%
OM growth 3Y-17.8%
OM growth 5Y20.31%
PM growth 3Y-7.34%
PM growth 5YN/A
GM growth 3Y-4.26%
GM growth 5Y-3.06%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.2
Debt/EBITDA 0.38
Cap/Depr 165.57%
Cap/Sales 34.93%
Interest Coverage 21.87
Cash Conversion 95.73%
Profit Quality 31.13%
Current Ratio 0.94
Quick Ratio 0.88
Altman-Z 1.77
F-Score4
WACC8.69%
ROIC/WACC0.84
Cap/Depr(3y)173.67%
Cap/Depr(5y)227.89%
Cap/Sales(3y)27.34%
Cap/Sales(5y)32.88%
Profit Quality(3y)53.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.89%
EPS 3Y1.52%
EPS 5YN/A
EPS Q2Q%-33.52%
EPS Next Y-21.68%
EPS Next 2Y-6.99%
EPS Next 3Y-1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)34.76%
Revenue growth 3Y49.24%
Revenue growth 5Y20.44%
Sales Q2Q%50.79%
Revenue Next Year-3.88%
Revenue Next 2Y-1.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.12%
EBIT growth 3Y22.68%
EBIT growth 5Y44.91%
EBIT Next Year123.2%
EBIT Next 3Y33.36%
EBIT Next 5YN/A
FCF growth 1Y-52.38%
FCF growth 3Y33.26%
FCF growth 5Y149.9%
OCF growth 1Y15.24%
OCF growth 3Y31.89%
OCF growth 5Y18.62%